Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Reportlinker Adds Lung Cancer Drug Futures

October 19, 2010 12:33 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Oct. 19 /- Reportlinker.com announces that a new market research report is available in its catalogue: Lung Cancer Drug Futures http://www.reportlinker.com/p0315763/Lung-Cancer-Drug-Futures.html AN EXCEPTIONALLY COST EFFECTIVE SERVICE INCLUDING FORMATS TO MEET EVERY INFORMATION...

Baltimore to Host Largest Gathering of Cystic Fibrosis Scientists and Clinicians in the World

October 19, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

BETHESDA, Md., Oct. 19 /PRNewswire-USNewswire/ -- In the largest meeting of its kind, nearly 4,000 doctors, scientists, researchers and caregivers will meet in Baltimore, Md., Oct. 21 –23, 2010, to present the latest information and advancements on cystic fibrosis (CF) drug...

Pencil Beam Radiation Offers New Therapy Option for Lung Cancer Patients

October 19, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

HOUSTON, Oct. 19 /- Pencil beam scanning technology, an even more advanced and targeted form of radiation treatment known as proton therapy, is now being used to treat patients with lung cancer at The University of Texas MD Anderson Cancer Center.   Proton therapy derives its...

Advertisement

Mylan to Appeal Court Decision in Generic Paroxetine Hydrochloride CR Case

October 18, 2010 4:32 pm | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Oct. 18 /- Mylan Inc. (Nasdaq: MYL ) today announced that its motion for a preliminary injunction against GlaxoSmithKline and Apotex pertaining to generic Paxil CR was denied at a hearing today in the U.S. District Court for the District of New Jersey. The company believes...

New 2010 European Resuscitation Council Guidelines published

October 18, 2010 1:34 pm | by EurekAlert | News | Comments

(Elsevier) Elsevier announces the publication of the 2010 European Resuscitation Council Guidelines in the journal Resuscitation. These guidelines are based on an extensive international review of all the science supporting cardiopulmonary resuscitation (CPR), the 2010 International...

A new order for CPR, spelled C-A-B

October 18, 2010 6:31 am | by EurekAlert | News | Comments

(American Heart Association) The 2010 AHA Guidelines for CPR and ECC update the 2005 guidelines. When administering CPR, immediate chest compressions should be done first. Untrained lay people are urged to administer hands-only CPR (chest compressions only).

Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010

October 17, 2010 12:32 pm | by Bio-Medicine.Org | News | Comments

SAN CARLOS, Calif., Oct. 17 /- Nektar Therapeutics (Nasdaq: NKTR ) today presented new preclinical data demonstrating that NKTR-181, a mu-opioid analgesic with a novel molecular structure, dramatically reduces abuse liability while providing analgesia comparable to oxycodone and morphine....

Syndax Pharmaceuticals Announces Issuance of UK Patent for Entinostat

October 15, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., Oct. 15 /-  Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced the UK Intellectual Property Office allowed application GB0907347.9 entitled N-(2-aminophenyl)-4-[N-(pyridine-3-YL)-methoxycarbonyl-aminomethyl]-benzamide (MS-275)...

Advertisement

Cantel Medical Corp. Launches New Medical Face Mask Addressing Issue of Fit

October 15, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

LITTLE FALLS, N.J., Oct. 15 /- Cantel Medical Corp. (NYSE: CMN ), announced today the launch of a new, unique design of medical face masks - the SecureFit™ series by Crosstex International, a Cantel subsidiary and a leading U.S. manufacturer of medical face masks. The...

Mylan Receives Approvals for Generic Versions of Hyzaar® and Cozaar®

October 15, 2010 4:31 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Oct. 15 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approvals from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for the generic versions of Hyzaar® Tablets, 50...

Southeastern Michigan Gets First Ever FDA Approved Device That Destroys Fat Cells ... Without Surgery

October 15, 2010 3:31 am | by Bio-Medicine.Org | News | Comments

SHELBY TOWNSHIP, Mich., Oct 14 /- Allure Medical Spa, first in Michigan with the new FDA approved Coolsculpting™ by Zeltiq. Great news for men and women dealing with exercise and diet-resistant fat in areas like the tummy, love handles and back rolls! Allure Medical Spa of Shelby...

New Survey Highlights Immediate Need for Anesthesia Information Management Systems

October 14, 2010 12:31 pm | by Bio-Medicine.Org | News | Comments

ATLANTA, Oct. 14 /- A new survey highlights the need for Anesthesia Information Management Systems (AIMS) with a full 91 percent of respondents indicating that access to day-of-surgery data is Extremely Important or Important to optimally manage their anesthesia department.  More...

Scientists assess new vaccines to improve health of African children

October 14, 2010 7:31 am | by EurekAlert | News | Comments

(University of Liverpool) Scientists at the University of Liverpool, in partnership with the Malawi Ministry of Health, are investigating the effectiveness of new vaccines developed to protect children from pneumonia and diarrhoea.

Advertisement

Consumer Reports Flu Poll: Approximately Three Out of 10 Health Care Workers 'Living in a Bubble,' Not Getting Flu Vaccine

October 14, 2010 3:31 am | by Bio-Medicine.Org | News | Comments

YONKERS, N.Y., Oct. 14 /PRNewswire-USNewswire/ -- A new Consumer Reports Health poll reveals a disconcerting proportion of "at risk" groups who will not get the flu vaccine this year.  Of most concern, only 40% of Americans in the "work risk" category—meaning those who care for...

Yoga alleviates pain and improves function in fibromyalgia patients

October 13, 2010 9:31 pm | by EurekAlert | News | Comments

(Elsevier Health Sciences) Fibromyalgia (FM) is a debilitating condition affecting 11 million individuals in the US alone. Drug therapies are generally only 30 percent effective in relieving symptoms and 20 percent effective in improving function. Standard care currently includes...

OHSU research suggests yoga can counteract fibromyalgia

October 13, 2010 9:31 pm | by EurekAlert | News | Comments

(Oregon Health & Science University) According to new research conducted at Oregon Health & Science University, yoga exercises may have the power to combat the chronic pain caused by fibromyalgia -- a medical disorder characterized by chronic widespread pain.

PneumRx, Inc. Announces CE Mark Approval for Its RePneu® Lung Volume Reduction Coil (LVRC™) System

October 13, 2010 11:32 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Oct. 13 /- PneumRx, Inc. ( www.pneumrx.com ), a medical device company dedicated to bringing innovation and improvements to the treatment of lung disease, today announced that it has received CE Mark approval for its RePneu Lung Volume Reduction Coil (LVRC) System...

OLIGOMERIX, Inc. Announces Board Changes: Vic Micati Appointed Chairman and Jack Pasini Appointed Company Director and Chief Commercial Officer

October 13, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Oct. 13 /- OLIGOMERIX, Inc. announced today that Vic Micati, a Director since 2007, has been appointed Chairman of Oligomerix and that Jack Pasini has been appointed to the Company's Board of Directors and as Chief Commercial Officer.   Having worked at Pfizer Inc. (PFE)...

First phase II trial of heart disease treatment for Duchenne muscular dystrophy launched

October 12, 2010 10:31 am | by EurekAlert | News | Comments

(Kennedy Krieger Institute) Kennedy Krieger announced the launch of a first-of-its-kind phase II clinical trial to investigate a treatment for heart disease in Duchenne muscular dystrophy (DMD). Made possible by a $545,000 grant from Pilot Trials Now, a DMD initiative of Charley's Fund...

Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA

October 11, 2010 5:31 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario, Oct. 11 /- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: VRX) announced today that Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding Alexza's New Drug...

Michael R. Bristow, M.D. Ph.D. Joins Nile Therapeutics Scientific Advisory Board

October 7, 2010 5:31 pm | by Bio-Medicine.Org | News | Comments

SAN MATEO, Calif., Oct. 7 /- Nile Therapeutics, Inc. (Nasdaq: NLTX ), a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that Michael R. Bristow, M.D. Ph.D. has joined the Scientific Advisory Board overseeing the...

Bacteria to blame in asthma attacks in children

October 7, 2010 10:32 am | by EurekAlert | News | Comments

(University of Copenhagen) Doctors have long known that viral infections can bring about asthma attacks and the shortness of breath, coughing, and wheezing associated with them. But while viral infections cannot be treated, scientists at the Danish Paediatric Asthma Centre at the...

Due to Rising Costs of Asthma and Chronic Obstructive Pulmonary Disease Drugs, Managed Care Organization Pharmacy Directors Will be Forced to Tighten Their Formularies

October 6, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

NASHVILLE, Tenn. and GLEN ROCK, N.J., Oct. 6 /- HealthLeaders-InterStudy and Fingertip Formulary find that due to the rising costs of asthma and chronic obstructive pulmonary disease (COPD) drugs, managed care organization pharmacy directors will tighten their formularies. According to...

100,000th Patient Treated With Accuray's CyberKnife® Robotic Radiosurgery System

October 6, 2010 5:34 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Oct. 6 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that the 100,000th patient has been treated with the CyberKnife ® Robotic Radiosurgery System, a non-invasive alternative to surgery for the treatment of...

Powerful free radical causes lung damage from oxygen therapy

October 5, 2010 3:31 pm | by EurekAlert | News | Comments

(Medical College of Georgia) The most toxic free radical appears responsible for much of the lung damage that can result from oxygen therapy in the critically ill or injured, MCG researchers report. Within just a few days, ventilators and oxygen chambers used to significantly increase...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading